-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
December 01, 2013 - DEMENTIA INCLUDING ALZHEIMER'S #04
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 04: Dementia (Including Alzheimer’s
Disease)
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
R…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation_executive.pdf
June 01, 2012 - 1.7 million TBIs that
were recorded annually between 2002
and 2006,2 1.37 million patients were
treated … 275,000 were hospitalized,
and 50,000 died.2 Additional TBIs not
reflected in the numbers above are treated … disabilities, presumably
from moderate to severe TBI.10
Patients with moderate to severe TBI are typically treated … Outcome Conclusion SOE
Active-duty military personnel
with moderate to severe closed
head injury treated … single
study)
Veterans or active duty military
personnel with moderate to
severe closed head injury treated
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_research-protocol.pdf
February 01, 2008 - treatment of epilepsy, their known or
suspected mechanism of action, type of seizures principally treated … characteristics of antiepileptic medications1,2,7-9
Drug Name Mechanism
of Action
Seizure
Types
Treated … www.effectivehealthcare.ahrq.gov
Published Online: July 01, 2010
Drug Name Mechanism
of Action
Seizure
Types
Treated … www.effectivehealthcare.ahrq.gov
Published Online: July 01, 2010
Drug Name Mechanism
of Action
Seizure
Types
Treated … difference between the minimum effective and
minimum toxic concentrations are close together), should be treated
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_2-user-guide-to-ocer_130129.pdf
January 01, 2011 - time trends), and self-controlled case series (estimating the immediate
effect of treatment in those treated … those among older
adults.8-11 Because frail persons (those close to
death) are less likely to be treated … effect
of treatment versus no treatment on the outcome
to the short-term effect of treatment in those
treated … design, the self-
controlled case-series design estimates the
immediate effect of treatment in those treated … This observation time is
divided into treated person-time, a washout period
of person-time, and untreated
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
September 27, 2012 - To be considered a candidate for ablation
or radiation therapy, patients treated in this setting should … cancer
state that ablative therapy can be considered when all measurable metastatic disease can be
treated … Patients whose liver metastases are resectable, those who have unresectable liver metastases
treated … first-line chemotherapy in combination with liver-directed therapy for downstaging
of disease, and those treated
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
January 01, 2016 - These children, younger than 5
years of age, are treated with an insulin pump, continuous glucose sensor … Ranibizumab-treated patients underwent
significantly fewer macular laser procedures (mean of 1.8 and … In patients treated with laser alone in the
core study, the mean BCVA, CRT, and NEI VFQ-25 composite … Patients were treated with Lucentis 0.5 mg (monotherapy or combined with laser)
or laser alone for … Alimera Sciences announces first patient treated
with commercially available Iluvien.
-
effectivehealthcare.ahrq.gov/sites/default/files/s38.pdf
October 01, 2007 - Furthermore, if pa-
tients share information with others treated by the same
provider, assignment of … practice or individual providers; what magnitude of clustering
should be anticipated among patients treated … to quantify agreement in treatments among
patients of the same provider, as well as among patients
treated … the intracluster
correlation coefficient quantifies the strength of agreement
in Y between 2 patients treated
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-appendix-e.xlsx
July 15, 2025 - Digestible Carbohydrate Intake and Maternal-Infant Outcomes: Appendix E Tables
E-1. ROB RCT
Table E-1. Risk of bias of RCTs
Author, Year Is randomization adequate?
Yes/No/Unclear Is allocation concealment adequate?
Yes/No/Unclear Are groups similar at baseline?
Yes/No/Unclear Is the outcome assessor (intervi…
-
effectivehealthcare.ahrq.gov/products/diabetic-neuropathy
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
January 01, 2015 - In September 2014, FDA
approved Iluvien® for treating DME in patients “who have been previously treated … However, some
experts noted that cost savings could be nullified if patients need to be treated for … FDA, Iluvien was granted marketing approval for treating
DME in patients “who have been previously treated … device, leads to sustained improved
glycemic control and weight loss for 48 weeks in
metformin-treated … Alimera Sciences announces first patient treated
with commercially available Iluvien.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_executive.pdf
June 01, 2013 - concepts—
weight and disorders of glucose metabolism—that are
a continuum physiology, but in the KQs, are treated … were
statistically significantly better weight loss and glucose
control outcomes in the patients treated … with bariatric
surgery compared to those treated nonsurgically.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
June 16, 2010 - or darbepoetin treatment
(compared to no treatment, to placebo, or to each other) in patients being treated … In an individual patient data meta-analysis of 13,933 patients in 53 trials
treated with epoetin alfa … Did the participants in the study have a previously treated or untreated
malignant disease?
3. … Did the participants in the study have a previously treated or untreated
malignant disease?
5. … “intention-to-treat” and
“as treated” analyses, we will use the intention-to-treat based data for a
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
May 01, 2013 - The median time
to disease progression was 9.5 months (range: 1.0 to 47.3 months)
in patients treated … with TACE and 10.4 months (range: 1.0 to 42.7
months) in patients treated with RFA (p = 0.95). … In addition, TTP and
local recurrence may be improved in patients treated with
RFA compared with PEI … treated with PEI/PAI. … For example, the size
of lesions being treated with RFA ranged from 4 cm or
smaller in the trial by
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
September 26, 2014 - In December 2013, the manufacturer reported
outcomes from a study involving 447 patients with T2DM treated … However, some
experts noted that cost savings could be nullified if patients need to be treated for … In December 2013, the manufacturer reported outcomes from a study involving
447 patients with T2DM treated … March 2013, Mathieu and colleagues reported outcomes from a study involving 493 patients
with T1DM treated … Alimera Sciences announces first patient treated
with commercially available Iluvien.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
March 01, 2012 - Few studies involved a representative patient
sample treated in a typical clinical setting over a long … What are the incidence, timing, and clinical consequences of
angioedema in patients treated with ACEIs … Few studies involved a representative patient
sample treated in a typical clinical setting over a long … What are the incidence, timing, and clinical consequences of
angioedema in patients treated with ACEIs … Evaluation of the incidence, timing, and clinical consequences of angioedema
in patients treated with
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pelvic-pain_executive.pdf
January 01, 2012 - Pelvic Pain_Layout 1 12/15/11 9:56 AM Page 6
7
Given that many women with CPP are treated with … There
is no assurance that the treated condition is the
causative condition. … Chronic pelvic pain treated with gabapentin and
amitriptyline: a randomized controlled pilot study.
-
effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
January 01, 2012 - Urinary retention was reported
as an adverse event in 29 out of 1,365 (approximately 2%) patients treated … Researchers stated that patients treated with icatibant reported significantly faster initial
symptom … Five patients treated with icatibant reported treatment-related adverse events that included
diarrhea … with Levadex might not
experience nausea and vomiting as often as patients treated with intravenous … Patients experiencing more severe symptoms and those who do
not respond to NSAIDs may be treated with
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
October 07, 2011 - the studies that did report episodes of angioedema, this adverse
event was observed only in patients treated … that angioedema can prove fatal,
particularly among African Americans and the uninsured, who may be
treated … anaphylactoid
reactions have been reported in some patients dialyzed high-flux
membranes (e.g., AN69®) and treated … “Outcomes in
Hypertensive Patients at High Cardiovascular Risk Treated with
Regimens Based on Valsartan
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
September 08, 2011 - Key Question 2: In selected populations of patients who are being treated for local or
systemic infection … www.effectivehealthcare.ahrq.gov
Published Online: September 8, 2011
Adult and pediatric patients being treated … exacerbation of chronic obstructive pulmonary disease
o Pneumonia
o Osteomyelitis
Patients being treated
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
July 13, 2011 - patients on
extended release venlafaxine experienced nausea and vomiting less commonly than
patients treated